1. LGG-31. SUSTAINED OBJECTIVE RESPONSE TO DABRAFENIB THERAPY ACROSS DIFFERENT BRAIN HISTOLOGIES HARBOURING BRAF V600E ACTIVATING MUTATION. Issue 2 (22nd June 2018) Authors: Sumerauer, David; Krskova, Lenka; Kyncl, Martin; Zapotocky, Michal; Kuklova, Adela; Zamecnik, Josef; Ondrova, Barbora; Stary, Jan Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗